To help find ways to quantify COVID-19 antibodies in individuals over time and across populations, Beckman Coulter announces a fully quantitative and automated COVID-19 antibody test traceable to the first WHO International Standard. The test is now available under the US FDA’s Policy D and helps address unknowns around COVID-19 antibody testing, such as the efficacy and longevity of the COVID-19 immune response, the role of COVID-19 antibody testing in a vaccinated world, and how to determine and treat those who have post-acute sequelae of COVID-19.

• Beckman Coulter